[PTE] Presidential talk event
Is glass ceiling present? Toward the equal opportunity of women in child neurology

[PTE-1] From Pediatrics to Geriatrics with Fragile X: A Woman’s Journey in Medicine

Randi J. Hagerman (University of California Davis Medical Center, USA)

Randi J. Hagerman, M.D., FAAP, is a Distinguished Professor of Pediatrics at the University of California Davis Medical Center and Director of the Fragile X Research and Treatment Center at the MIND Institute and holds an Endowed Chair in Fragile X Research. Dr. Hagerman is a developmental and behavioral pediatrician and has studied patients with fragile X syndrome (FXS), autism (ASD), and other neurodevelopmental disorders. She has carried out numerous targeted treatment studies in FXS and autism. She and her husband and team have published extensively regarding fragile X premutation disorders including the first description of FXTAS in 2001. She co-founded the National Fragile X Foundation in 1984 and has been involved in targeted treatments for fragile X syndrome, autism, and FXTAS for several years. Dr Hagerman has written over 400 peer-reviewed articles and several books on fragile X and autism. Her most recent books are R. Hagerman and R. Hendren (eds) (2014) Treatment of Neurodevelopmental Disorders: Targeting Neurobiological Mechanisms published by Oxford University Press and, E. Hollander, R. Hagerman and D. Fein (eds) (2018) Autism Spectrum Disorders, American Psychiatric Association Publishing.